My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

3.485 -0.215 (-5.81%)

Streaming Delayed Price Updated: 10:05 AM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

18 Stocks Moving in Friday's Pre-Market Session ↗

February 04, 2022

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Have a look at this: Insiders Buying Charter Communications...

Via Benzinga

CNS Pharmaceuticals Laying Foundation For Potentially Pivotal Global Trial ↗

February 03, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Via Benzinga

CNS Pharmaceuticals (NASDAQ: CNSP) Laying Foundation for Potentially Pivotal Global Trial

February 03, 2022

Via Investor Brand Network

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Laying Robust Foundation for Potentially Pivotal Global Trial

February 02, 2022

Via Investor Brand Network

CNS Pharmaceuticals Marks Milestone In Pursuit Of Berubicin Approval For GBM ↗

January 26, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 03, 2022

On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 31, 2022

Gainers Oncternal Therapeutics (NASDAQ:ONCT

Via Benzinga

CNS Pharmaceuticals (NASDAQ: CNSP) Marks Milestone in Pursuit of Berubicin Approval for GBM

January 26, 2022

Via Investor Brand Network

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Marks Significant Milestone in Pursuit of Berubicin Approval for Global GBM Treatment, Raises $11.5 Million from Private Placement

January 25, 2022

Via Investor Brand Network

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 21, 2022

Gainers Mustang Bio (NASDAQ:MBIO) shares ...

Via Benzinga

CNS Pharmaceuticals to Present at Virtual Investor 2022 Top Picks Conference ↗

January 21, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals (NASDAQ: CNSP), a...

Via Benzinga

CNS Pharmaceuticals (NASDAQ: CNSP) to Present at Virtual Investor 2022 Top Picks Conference

January 21, 2022

Via Investor Brand Network

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Virtual Investor 2022 Top Picks Conference

January 20, 2022

Via Investor Brand Network

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 13, 2022

Gainers iSpecimen (NASDAQ:ISPC) shares rose 19.8% to $8.18 during Thursday's pre-market session. The market value of their outstanding shares is at $71.4 million. VYNE...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 13, 2022

Good morning, investor! We're starting off the day right with a look at the biggest pre-market stock movers for Thursday!

Via InvestorPlace

JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th

January 12, 2022

- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ /...

From JTC Team, LLC

Via AccessWire

CNS Pharmaceuticals Closes on $11.5M Private Placement ↗

January 11, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals (NASDAQ: CNSP), a...

Via Benzinga

CNS Pharmaceuticals (NASDAQ: CNSP) Closes on $11.5M Private Placement

January 11, 2022

Via Investor Brand Network

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Closes on $11.5M Private Placement

January 11, 2022

Via Investor Brand Network

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate at H.C. Wainwright BioConnect Conference

January 07, 2022

Via Investor Brand Network

CNS Pharmaceuticals Announces $11.5M Private Placement ↗

January 07, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. CNS Pharmaceuticals (NASDAQ: CNSP), a...

Via Benzinga

CNS Pharmaceuticals (NASDAQ: CNSP) Announces $11.5M Private Placement

January 07, 2022

Via Investor Brand Network

58 Biggest Movers From Yesterday ↗

January 07, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...

Via Benzinga

Mid-Afternoon Market Update: Gold Drops 2%; Berkeley Lights Shares Plummet ↗

January 06, 2022

Toward the end of trading Thursday, the Dow traded down 0.35% to 36,278.43 while the NASDAQ rose 0.22% to 15,133.94. The S&P also rose 0.14% to 4,707.37. The U.S. has the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 06, 2022

Gainers Eargo (NASDAQ:EAR) stock increased by 50.0% to $6.84 during Thursday's regular session. The current volume of 90.4 million shares is 5474.6% of Eargo's...

Via Benzinga

Mid-Day Market Update: Nasdaq Turns Higher; Vocera Communications Shares Surge ↗

January 06, 2022

Midway through trading Thursday, the Dow traded down 0.34% to 36,284.59 while the NASDAQ rose 0.18% to 15,127.00. The S&P, however, rose 0.07% to 4,703.93. The U.S. has the...

Via Benzinga

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Agreements Totaling $11.5M for Gross Proceeds

January 06, 2022

Via Investor Brand Network

33 Stocks Moving In Thursday's Mid-Day Session ↗

January 06, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗

January 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 06, 2022

Gainers Freeline Therapeutics (NASDAQ:FRLN) stock increased by 58.1% to $3.1 during Thursday's pre-market session. The company's market cap stands at $111.0...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.